Luken Investment Analytics’s AstraZeneca AZN Stock Holding History

Luken Investment Analytics’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$142K	Hold	750	–	–	0.05%	71
2026 Q1	$148K	Sell	750 -32	-4%	-$6.17K	0.06%	60
2025 Q4	$144K	Buy	782 +32	+4%	+$5.61K	0.06%	60
2025 Q3	$115K	Hold	750	–	–	0.05%	68
2025 Q2	$105K	Hold	750	–	–	0.05%	66
2025 Q1	$110K	Hold	750	–	–	0.05%	66
2024 Q4	$98.3K	Hold	750	–	–	0.05%	61
2024 Q3	$117K	Hold	750	–	–	0.05%	60
2024 Q2	$117K	Hold	750	–	–	0.06%	59
2024 Q1	$102K	Hold	750	–	–	0.05%	58
2023 Q4	$101K	Hold	750	–	–	0.05%	58
2023 Q3	$102K	Hold	750	–	–	0.06%	57
2023 Q2	$107K	Hold	750	–	–	0.06%	53
2023 Q1	$104K	Hold	750	–	–	0.06%	52
2022 Q4	$102K	Buy	+750	New	+$94.1K	0.06%	53
2020 Q4	$75K	Buy	+750	New	+$79.4K	0.06%	45

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Luken Investment Analytics's AZN Position: Q2 2026 in Review

Luken Investment Analytics held its AstraZeneca (AZN) position steady in Q2 2026 at 750 shares worth $142K. The position accounts for 0.05% of the portfolio, ranked #71.

Luken Investment Analytics first reported a position in AZN in Q4 2020 and has held it in 16 quarters since. The position peaked at $148K in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Luken Investment Analytics held 750 shares of AstraZeneca worth $142K as of Q2 2026.
Luken Investment Analytics left its AstraZeneca share count unchanged in Q2 2026.
AstraZeneca made up 0.05% of Luken Investment Analytics's portfolio in Q2 2026, its #71 holding.
Luken Investment Analytics first reported a position in AstraZeneca in Q4 2020 and has held it in 16 quarters since.
Luken Investment Analytics's AstraZeneca position peaked at $148K in Q1 2026.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Luken Investment Analytics's 13F filing for Q2 2026, filed 28 Jul 2026.